Asahi Kasei Corp.’s (Tokyo, Japan) Medical business has decided to expand production capacity of hydrophilic PVDF (polyvinylidene fluoride) hollow-fiber membranes for Planova BioEX filters at its spinning plant in Oita, Japan. The global COVID-19 pandemic has increased the urgent demand for Planova filters, which are indispensable to develop and mass-produce anti-coronavirus agents. Asahi Kasei Medical will double spinning production capacity at this site by utilizing its state-of-the-art technology. The capacity increase is expected to commence in the fourth quarter of calendar year 2022.
Asahi Kasei Medical will continue to reinforce its global supply infrastructure for Planova through proactive investments in manufacturing facilities in order to support the early provision of vaccines and life-saving therapies to as many people as possible.